Literature DB >> 1267637

Treatment of Behcet disease with chlorambucil. A follow-up report.

J G Mamo.   

Abstract

In Behcet disease the eyes are involved in most cases, and progression to blindness is almost the rule. When the central nervous system is involved, the prognosis for life is grave. In a preliminary report, 11 patients had the disease arrested as a result of treatment with chlorambucil. Some of these patients had long-term follow-up and are included in this report. Nine others received the same treatment, resulting in arrest of the disease in eight and pronounced improvement in one. Long-term follow-up, in some patients for more than five years after arrest of the disease, has not disclosed any recurrence. These results may appear more important if it is noted that blindness in Behcet disease occurs an average of 3.36 years after onset of eye symptoms.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1267637     DOI: 10.1001/archopht.1976.03910030274004

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

Review 1.  Standard and novel therapeutic approaches to Behçet's disease.

Authors:  Ahmet Gul
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease.

Authors:  H H Tessler; T Jennings
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

3.  Treatment and visual prognosis in Behçet's disease.

Authors:  D Benezra; E Cohen
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

4.  Behçet's syndrome: treatment with chlorambucil.

Authors:  J H Elliott; W H Ballinger
Journal:  Trans Am Ophthalmol Soc       Date:  1984

5.  Immunosuppressive therapy of ocular disease.

Authors:  W B Boone; L Slater
Journal:  J Natl Med Assoc       Date:  1979-09       Impact factor: 1.798

Review 6.  Emerging drugs for uveitis.

Authors:  Theresa Larson; Robert B Nussenblatt; H Nida Sen
Journal:  Expert Opin Emerg Drugs       Date:  2011-01-06       Impact factor: 4.191

7.  Retinal and disc neovascularization in Behçet's disease and efficacy of laser photocoagulation.

Authors:  L S Atmaca; F Batioğlu; A Idil
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-02       Impact factor: 3.117

Review 8.  Pharmacotherapy of scleritis: current paradigms and future directions.

Authors:  Robert M Beardsley; Eric B Suhler; James T Rosenbaum; Phoebe Lin
Journal:  Expert Opin Pharmacother       Date:  2013-02-21       Impact factor: 3.889

Review 9.  The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.

Authors:  S Mishima; K Masuda; Y Izawa; M Mochizuki; K Namba
Journal:  Trans Am Ophthalmol Soc       Date:  1979
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.